ABRF 2019: Simultaneous DNA and RNA Extraction from Formalin-Fixed Paraffin Embedded (FFPE) Tissue
Content Type: Poster
Authors: Han Wei, Ph.D.; Brittany Niccum Ph.D.; Zach Smith, M.S.; Jimmy Adediran, M.S.
Formalin-fixed, paraffin-embedded (FFPE) tissue is an invaluable study resource for research, especially for biomarker detection. The advances in Next Generation Sequencing (NGS) allows researchers to study genomes, epigenomes and transcriptomes using limited sample material such as FFPE tissue. However, there are challenges for nucleic acids extraction from FFPE tissue due to how FFPE samples are prepared. The nucleic acid quality and integrity are often affected by duration of tissue fixation, age, and storage condition of tissue blocks, and the extraction method.
Here we present a streamlined NGS ready to use sample prep workflow for FFPE tissue using FormaPure XL Total. FormaPure XL Total uses SPRI (Solid Phase Reverse Immobilization) paramagnetic beads to isolate DNA and RNA simultaneously. Up to 7 x 10 µm/curls of FFPE tissue can be processed by FormaPure XL Total in a single reaction. For researchers who have high throughput needs, we implemented an automated FFPE extraction method on a Biomek i-Series using FormaPure XL Total. A total of 7 FFPE tissues that represent 4 different tumor types: liver, large intestine, breast and brain were demonstrated on a Biomek i5 *. The work flow takes less than 6.5 hours with only 30 minutes hands on time. FormaPure XL Total provides consistent and efficient extraction performance from FFPE tissues, and it is easy to accommodate tissue input variations.
Challenges with FFPE Samples
Why Trust Beckman Extraction?
Figure 1. AMPure XP chemistry is based on SPRI (Solid Phase Reverse Immobilization) paramagnetic bead technology, where the Nucleic acid is immobilized on beads, contaminants washed away, then eluted. FormaPure XL pairs SPRI bind, wash, elute workflow with upfront lysis and deparaffinization.
FormaPure XL Manual Performance Data
Figure 2. FormaPure XL workflow. FormaPure XL Total uses SPRI paramagnetic beads to isolate DNA and RNA simultaneously. DNA (B) and RNA (C) manual extraction using FormaPure XL. 5 and 7 curls of Colon and stomach cancer FFPE tissues were used in this demonstration. DNA and RNA were quantified by Quant-iT PicoGreen dsDNA Assay and Quant-iT RiboGreen RNA Assay, respectively. Increasing the number of curls can increase the total nucleic acid extracted.
Automated FormaPure XL Performance Data
Figure 3. FormaPure XL Total is automated on Biomek i-Series. 7 FFPE tissues that represent 4 different tumor types: liver, large intestine, breast and brain were demonstrated on a i5 Span-8 platform. Sample process time comparison between manual and Biomek automation (A). DNA and RNA were quantified by Quant-iT PicoGreen dsDNA Assay and Quant-iT RiboGreen RNA Assay, respectively (B). The nucleic acid integrity was measured by DV200 (C). Biomek i5 deck layout for nucleic acid extraction from FFPE tissues (D).
FormaPure XL Performance Comparison
Figure 4. FFPE-derived nucleic acid yield and integrity comparison. Column based method and FormaPure XL total were used in this demonstration. DNA and RNA were quantified by Quant-iT PicoGreen dsDNA Assay and Quant-iT RiboGreen RNA Assay, respectively (A and B). DNA and RNA yields can be balanced by adjusting lysis times. The nucleic acid integrity was measured by DV200 (C). RNA yield that fragments > 200 nt in size (D) was calculated use Total RNA yield * DV200 (%).
Non-IVD disclaimer: Not intended or validated for use in the diagnosis of disease or other conditions.
Beckman Coulter makes no warranties of any kind whatsoever express or implied, with respect to this protocol, including but not limited to warranties of fitness for a particular purpose or merchantability or that the protocol is non-infringing. All warranties are expressly disclaimed. Your use of the method is solely at your own risk, without recourse to Beckman Coulter. Not intended or validated for use in the diagnosis of disease or other conditions. This protocol is for demonstration only and is not validated by Beckman Coulter. Trademark statement: Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are the trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners.